Re-Purposing the Ordering of 'Routine' Laboratory Tests in Hospitalized Medical Patients (RePORT Study)

NCT06119464 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 251817

Last updated 2024-12-19

No results posted yet for this study

Summary

Laboratory test overuse occurs when tests are ordered repetitively, without due consideration of impact on clinical status. Repetitive inpatient lab testing often provides limited value for patient outcomes while increasing healthcare costs, patient discomfort, and unnecessary transfusions and prolonging hospitalizations. The research study aims to reduce laboratory test overuse in hospitals through implementation of a comprehensive, multi-disciplinary, and multi-faceted intervention bundle that includes audit and feedback reports, clinician education, clinical decision support tool, and patient infographics across 14 hospitals in Alberta.

Conditions

  • Utilization, Health Care

Interventions

OTHER

Multimodal Intervention: Education

The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.

OTHER

Multimodal Intervention: Audit and Feedback

The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.

OTHER

Multimodal Intervention: Patient Engagement

The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.

OTHER

Multimodal Intervention: System Changes

The multimodal intervention bundle consists of education, audit and feedback, patient engagement, and system changes.

Sponsors & Collaborators

  • Alberta Health services

    collaborator OTHER
  • University of British Columbia

    collaborator OTHER
  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV
  • University of Calgary

    lead OTHER

Principal Investigators

  • Anshula Ambasta · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-02
Primary Completion
2024-10-31
Completion
2025-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06119464 on ClinicalTrials.gov